Transposon Therapeutics, Inc.
Laguna Niguel, CA
- UEI
- Z24RDQEEEP36
- CAGE
- 149C5
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 34 Emerald Glen, Laguna Niguel, CA 92677, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| (no IDC) project title: development of human line-1 reverse transcriptase inhibitors for the treatment of amyotrophic… | Defense Health Agency | $1,920,457 |
Quick answers
What is Transposon Therapeutics, Inc.'s UEI?
Transposon Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is Z24RDQEEEP36.
What is Transposon Therapeutics, Inc.'s CAGE code?
Transposon Therapeutics, Inc.'s CAGE code is 149C5.
What is Transposon Therapeutics, Inc.'s primary NAICS code?
Transposon Therapeutics, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Transposon Therapeutics, Inc. located?
Transposon Therapeutics, Inc.'s physical address in SAM.gov is 34 Emerald Glen, Laguna Niguel, CA 92677, USA.
Is Transposon Therapeutics, Inc. registered in SAM.gov?
Yes. Transposon Therapeutics, Inc.'s SAM.gov registration is active through May 26, 2027.
What is Transposon Therapeutics, Inc.'s most recent federal award?
Transposon Therapeutics, Inc.'s most recent federal grant award is (no IDC) project title: development of human line-1 reverse transcriptase inhibitors for the treatment of amyotrophic… (HT9425261E204), from Defense Health Agency, on May 15, 2026.
On GovTribe
See Transposon Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors